-+ 0.00%
-+ 0.00%
-+ 0.00%

Definium Therapeutics Q4 EPS $(0.50) Misses $(0.46) Estimate.

Benzinga·02/26/2026 21:03:33
Listen to the news
Definium Therapeutics (NASDAQ:DFTX) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.46) by 7.76 percent. This is a 21.95 percent decrease over losses of $(0.41) per share from the same period last year.